Literature DB >> 29557284

Amino Acid Transporters as Disease Modifiers and Drug Targets.

Stefan Bröer1.   

Abstract

Amino acids perform a variety of functions in cells and organisms, particularly in the synthesis of proteins, as energy metabolites, neurotransmitters, and precursors for many other molecules. Amino acid transport plays a key role in all these functions. Inhibition of amino acid transport is pursued as a therapeutic strategy in several areas, such as diabetes and related metabolic disorders, neurological disorders, cancer, and stem cell biology. The role of amino acid transporters in these disorders and processes is well established, but the implementation of amino acid transporters as drug targets is still in its infancy. This is at least in part due to the underdeveloped pharmacology of this group of membrane proteins. Recent advances in structural biology, membrane protein expression, and inhibitor screening methodology will see an increased number of improved and selective inhibitors of amino acid transporters that can serve as tool compounds for further studies.

Entities:  

Keywords:  cancer; diabetes; drug development; solute carrier

Mesh:

Substances:

Year:  2018        PMID: 29557284     DOI: 10.1177/2472555218755629

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  10 in total

Review 1.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Amino acids and amino acid sensing: implication for aging and diseases.

Authors:  Serena Dato; Eneida Hoxha; Paolina Crocco; Francesca Iannone; Giuseppe Passarino; Giuseppina Rose
Journal:  Biogerontology       Date:  2018-09-25       Impact factor: 4.277

Review 3.  The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology.

Authors:  Mariafrancesca Scalise; Lorena Pochini; Lara Console; Maria A Losso; Cesare Indiveri
Journal:  Front Cell Dev Biol       Date:  2018-09-04

4.  Mice Lacking the Intestinal and Renal Neutral Amino Acid Transporter SLC6A19 Demonstrate the Relationship between Dietary Protein Intake and Amino Acid Malabsorption.

Authors:  Kiran Javed; Stefan Bröer
Journal:  Nutrients       Date:  2019-08-29       Impact factor: 5.717

Review 5.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

6.  The 2020 SLAS Discovery Top 10: Advancing the Science of Drug Discovery.

Authors:  Robert M Campbell
Journal:  SLAS Discov       Date:  2021-02       Impact factor: 3.341

7.  Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells.

Authors:  Gregory Gauthier-Coles; Angelika Bröer; Malcolm Donald McLeod; Amee J George; Ross D Hannan; Stefan Bröer
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

8.  Development of Biomarkers for Inhibition of SLC6A19 (B⁰AT1)-A Potential Target to Treat Metabolic Disorders.

Authors:  Kiran Javed; Qi Cheng; Adam J Carroll; Thy T Truong; Stefan Bröer
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

9.  Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets.

Authors:  Angelika Bröer; Stephen Fairweather; Stefan Bröer
Journal:  Front Pharmacol       Date:  2018-07-19       Impact factor: 5.810

10.  Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19.

Authors:  Mariafrancesca Scalise; Cesare Indiveri
Journal:  SLAS Discov       Date:  2020-06-05       Impact factor: 3.341

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.